Cleared Traditional

K083842 - ROTEM DELTA THROMBOELASTOMETRY SYSTEM

K083842 is an FDA 510(k) clearance for ROTEM DELTA THROMBOELASTOMETRY SYSTEM, manufactured by Pentapharm GmbH. The device is a Class 2 Hematology device with product code JPA cleared through the Traditional 510(k) pathway after a 454-day FDA review.

K083842 · Pentapharm GmbH · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2010
Decision
454d
Days
Class 2
Risk

K083842 is an FDA 510(k) clearance for the ROTEM DELTA THROMBOELASTOMETRY SYSTEM. Classified as System, Multipurpose For In Vitro Coagulation Studies (product code JPA), Class II - Special Controls.

Submitted by Pentapharm GmbH (Munich, DE). The FDA issued a Cleared decision on March 23, 2010 after a review of 454 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5425 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Hematology submissions.

View all Pentapharm GmbH devices

FDA 510(k) Submission Details - K083842

510(k) Number K083842 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 24, 2008
Decision Date March 23, 2010
Days to Decision 454 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
341d slower than avg
Panel avg: 113d · This submission: 454d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JPA Device Classification - Class 2, Special Controls

Product Code JPA System, Multipurpose For In Vitro Coagulation Studies
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - JPA System, Multipurpose For In Vitro Coagulation Studies

All 160
Devices cleared under the same product code (JPA) and FDA review panel - the closest regulatory comparables to K083842.
STA R MAX
K151867 · Diagnostica Stago S.A.S · Aug 2015
CORA (Coagulation Resonance Analysis) System
K150041 · Coramed Technologies, LLC · Jun 2015
STA COMPACT MAX
K130090 · Diagnostica Stago, Incorporated · Feb 2013
STA COMPACT AUTOMATED MULTI-PARAMETRIC ANALYZER
K093167 · Diagnostica Stago, Inc. · Dec 2009
ACL ACUSTAR, HEMOSIL ACUSTAR D-DIMER, HEMOSIL ACUSTAR D-DIMER CONTROLS
K083518 · Instrumentation Laboratory CO · Mar 2009
BERICHROM HEPARIN LMW CALIBRATOR, BERICHROM HEPARIN LMW CONTROL 1, AND BERICHROM HEPARIN LMW CONTROL 2
K083159 · Siemens Healthcare Diagnostics · Jan 2009